The love of good tea is in human nature even though a subset of people prefer a scintillating cup of coffee. Coffee is arguably one of the most popular drinks on the planet and is a complex cocktail.
In fact, coffee can contain more than 1000 nonvolatile chemical compounds and in excess of 1,500 volatile ones.
So while the chemical compounds present depends on a lot of factors, including how the maker prepare the coffee beans, scientist have been able to isolate some of these chemicals that affect prostate cancer in men.
Recent studies have started identifying links between coffee consumption and lower prostate cancer risk. As evidence mounts, people are directing more attention to this relationship.
Researchers from Kanazawa University Graduate School of Medical Science in Japan tested a range of coffee compounds against prostate cancer in mice. Specifically, they used cells that were resistant to standard cancer drugs, such as cabazitaxel.
This week, the scientists presented their results at the European Association of Urology congress in Barcelona, Spain. In December 2018, they also published their findings in the journal The Prostate.
Initially, the scientists looked at the effects of six coffee compounds. Then, they narrowed their focus to just two: kahweol acetate and cafestol. Both chemicals are hydrocarbons that naturally occur in Arabica coffee.
In their preliminary experiments, they showed that when they added kahweol acetate and cafestol to prostate cancer cells in a petri dish, the cells grew less rapidly.